Impact of Training and Municipal Support on Primary Health Care-Based Measurement of Alcohol Consumption in Three Latin American Countries: 5-Month Outcome Results of the Quasi-experimental Randomized SCALA Trial.

AUDIT-C Colombia Institute for Health Care Improvement Mexico Peru brief advice heavy drinking implementation measurement of alcohol consumption municipal action primary health care

Journal

Journal of general internal medicine
ISSN: 1525-1497
Titre abrégé: J Gen Intern Med
Pays: United States
ID NLM: 8605834

Informations de publication

Date de publication:
09 2021
Historique:
received: 31 07 2020
accepted: 17 12 2020
pubmed: 21 1 2021
medline: 3 9 2021
entrez: 20 1 2021
Statut: ppublish

Résumé

We aimed to test the effects of providing municipal support and training to primary health care providers compared to both training alone and to care as usual on the proportion of adult patients having their alcohol consumption measured. We undertook a quasi-experimental study reporting on a 5-month implementation period in 58 primary health care centres from municipal areas within Bogotá (Colombia), Mexico City (Mexico), and Lima (Peru). Within the municipal areas, units were randomized to four arms: (1) care as usual (control); (2) training alone; (3) training and municipal support, designed specifically for the study, using a less intensive clinical and training package; and (4) training and municipal support, designed specifically for the study, using a more intense clinical and training package. The primary outcome was the cumulative proportion of consulting adult patients out of the population registered within the centre whose alcohol consumption was measured (coverage). The combination of municipal support and training did not result in higher coverage than training alone (incidence rate ratio (IRR) = 1.0, 95% CI = 0.6 to 0.8). Training alone resulted in higher coverage than no training (IRR = 9.8, 95% CI = 4.1 to 24.7). Coverage did not differ by intensity of the clinical and training package (coefficient = 0.8, 95% CI 0.4 to 1.5). Training of providers is key to increasing coverage of alcohol measurement amongst primary health care patients. Although municipal support provided no added value, it is too early to conclude this finding, since full implementation was shortened due to COVID-19 restrictions. Clinical Trials.gov ID: NCT03524599; Registered 15 May 2018; https://clinicaltrials.gov/ct2/show/NCT03524599.

Identifiants

pubmed: 33469752
doi: 10.1007/s11606-020-06503-9
pii: 10.1007/s11606-020-06503-9
pmc: PMC7815287
doi:

Banques de données

ClinicalTrials.gov
['NCT03524599']

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2663-2671

Subventions

Organisme : Department of Health
ID : NIHR300616
Pays : United Kingdom
Organisme : Horizon 2020 Framework Programme
ID : 778048

Informations de copyright

© 2021. The Author(s).

Références

PLoS One. 2014 Jul 08;9(7):e101981
pubmed: 25003371
Lancet. 2015 Mar 28;385(9974):1230-47
pubmed: 25458725
Addiction. 2017 Feb;112 Suppl 2:23-33
pubmed: 28074571
Eur J Public Health. 2017 Apr 1;27(2):345-351
pubmed: 27558943
Adicciones. 2014;26(4):291-302
pubmed: 25578000
Cochrane Database Syst Rev. 2018 Feb 24;2:CD004148
pubmed: 29476653
BMJ Open. 2016 Aug 11;6(8):e011473
pubmed: 27515753
Addiction. 2010 Jun;105(6):960-1; discussion 964-5
pubmed: 20659054
Ann Fam Med. 2017 Jul;15(4):335-340
pubmed: 28694269
JAMA. 2013 Sep 4;310(9):959-68
pubmed: 24002282
Addiction. 2017 Feb;112 Suppl 2:92-100
pubmed: 28074565
Lancet. 2015 Mar 28;385(9974):1248-59
pubmed: 25458715
Scand J Prim Health Care. 2006 Mar;24(1):5-15
pubmed: 16464809
Rev Panam Salud Publica. 2013 May;33(5):325-31
pubmed: 23764663
J Stud Alcohol. 2005 May;66(3):379-88
pubmed: 16047527
BMC Fam Pract. 2016 Jun 07;17:70
pubmed: 27267887
Arch Intern Med. 1998 Sep 14;158(16):1789-95
pubmed: 9738608
Front Psychiatry. 2014 Nov 11;5:161
pubmed: 25426083
Implement Sci. 2016 Jan 29;11:12
pubmed: 26821910
Addiction. 2017 Jun;112(6):968-1001
pubmed: 28220587
Alcohol Alcohol. 2004 Jul-Aug;39(4):351-6
pubmed: 15208170
Alcohol Alcohol. 2011 Sep-Oct;46(5):570-7
pubmed: 21690169
Alcohol Alcohol. 2015 Jul;50(4):430-7
pubmed: 25787012
Soc Sci Med. 2010 Mar;70(6):904-11
pubmed: 20089341
Lancet Public Health. 2020 Jan;5(1):e51-e61
pubmed: 31910980
Addiction. 2017 Feb;112 Suppl 2:110-117
pubmed: 28074569
Lancet. 2018 Apr 14;391(10129):1513-1523
pubmed: 29676281
Alcohol Alcohol. 2013 Mar-Apr;48(2):180-8
pubmed: 23015608
Lancet. 2016 Oct 8;388(10053):1659-1724
pubmed: 27733284
Br J Gen Pract. 2016 Jan;66(642):e1-9
pubmed: 26719481
Cochrane Database Syst Rev. 2017 Sep 25;9:CD011479
pubmed: 28944453
J Gen Intern Med. 2016 Jul;31(7):739-45
pubmed: 26862079
J Stud Alcohol. 2004 Mar;65(2):191-9
pubmed: 15151349
Addiction. 2011 May;106(5):906-14
pubmed: 21382111
F1000Res. 2017 Mar 23;6:311
pubmed: 29188013
Rev Peru Med Exp Salud Publica. 2016 Jul-Sep;33(3):432-437
pubmed: 27831605
Subst Use Misuse. 2017 Feb 23;52(3):359-372
pubmed: 28001094
Alcohol Alcohol. 2014 Jan-Feb;49(1):66-78
pubmed: 24232177
BMJ Open. 2020 Jul 28;10(7):e038226
pubmed: 32723746
Curr Opin Psychiatry. 2018 Jul;31(4):324-332
pubmed: 29846264
Cochrane Database Syst Rev. 2007 Apr 18;(2):CD004148
pubmed: 17443541
Circulation. 2016 Aug 9;134(6):441-50
pubmed: 27502908
Addiction. 2015 Dec;110(12):1877-900
pubmed: 26234486
Lancet. 2006 Nov 11;368(9548):1729-41
pubmed: 17098091

Auteurs

Peter Anderson (P)

Department of Health Promotion, CAPHRI Care and Public Health Research Institute, Maastricht University, Maastricht, The Netherlands. peter.anderson@maastrichtuniversity.nl.
Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK. peter.anderson@maastrichtuniversity.nl.

Jakob Manthey (J)

Institute for Clinical Psychology and Psychotherapy, TU Dresden, Dresden, Germany.
Center for Interdisciplinary Addiction Research (ZIS), Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Eva Jané Llopis (EJ)

Department of Health Promotion, CAPHRI Care and Public Health Research Institute, Maastricht University, Maastricht, The Netherlands.
Univ. Ramon Llull, ESADE, Barcelona, Spain.
Institute for Mental Health Policy Research, CAMH, Toronto, ON, Canada.

Guillermina Natera Rey (GN)

Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Ciudad de México, CDMX, Mexico.

Ines V Bustamante (IV)

School of Public Health and Administration, Universidad Peruana Cayetano Heredia, Lima, Peru.

Marina Piazza (M)

School of Public Health and Administration, Universidad Peruana Cayetano Heredia, Lima, Peru.

Perla Sonia Medina Aguilar (PSM)

Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Ciudad de México, CDMX, Mexico.

Juliana Mejía-Trujillo (J)

Corporación Nuevos Rumbos, Bogotá, Colombia.

Augusto Pérez-Gómez (A)

Corporación Nuevos Rumbos, Bogotá, Colombia.

Gill Rowlands (G)

Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.

Hugo Lopez-Pelayo (H)

Addictions Unit, Psychiatry Dept., Hospital Clínic, Barcelona, Spain.
Red de Trastornos Adictivos, Instituto Carlos III, Madrid, Spain.
Institut d'Investigacions Biomèdiques August Pi Sunyer (IDIBAPS), Barcelona, Spain.

Liesbeth Mercken (L)

Department of Health Promotion, CAPHRI Care and Public Health Research Institute, Maastricht University, Maastricht, The Netherlands.

Dasa Kokole (D)

Department of Health Promotion, CAPHRI Care and Public Health Research Institute, Maastricht University, Maastricht, The Netherlands.

Amy O'Donnell (A)

Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.

Adriana Solovei (A)

Department of Health Promotion, CAPHRI Care and Public Health Research Institute, Maastricht University, Maastricht, The Netherlands.

Eileen Kaner (E)

Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.

Bernd Schulte (B)

Center for Interdisciplinary Addiction Research (ZIS), Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Hein de Vries (H)

Department of Health Promotion, CAPHRI Care and Public Health Research Institute, Maastricht University, Maastricht, The Netherlands.

Christiane Schmidt (C)

Center for Interdisciplinary Addiction Research (ZIS), Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Antoni Gual (A)

Addictions Unit, Psychiatry Dept., Hospital Clínic, Barcelona, Spain.
Red de Trastornos Adictivos, Instituto Carlos III, Madrid, Spain.
Institut d'Investigacions Biomèdiques August Pi Sunyer (IDIBAPS), Barcelona, Spain.

Jürgen Rehm (J)

Institute for Clinical Psychology and Psychotherapy, TU Dresden, Dresden, Germany.
Institute for Mental Health Policy Research, CAMH, Toronto, ON, Canada.
Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
Department of International Health Projects, Institute for Leadership and Health Management, I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH